{"id":1311,"date":"2022-11-07T15:17:36","date_gmt":"2022-11-07T21:17:36","guid":{"rendered":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/?p=1311"},"modified":"2022-12-13T11:21:37","modified_gmt":"2022-12-13T17:21:37","slug":"fda-fast-tracks-codagenix-rsv-vaccine-candidate","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/2022\/11\/07\/fda-fast-tracks-codagenix-rsv-vaccine-candidate\/","title":{"rendered":"FDA Fast-Tracks Codagenix RSV Vaccine Candidate"},"content":{"rendered":"<div class=\"panel body-content\"><div class=\"panel__container\">\n<p>(<a href=\"https:\/\/www.contagionlive.com\/view\/fda-fast-tracks-codagenix-rsv-vaccine-candidate\">Contagion Live<\/a>) Codagenix Inc. announced the US Food and Drug Administration (FDA) recently granted Fast Track designation to CodaVax-RSV, their\u00a0respiratory syncytial virus (RSV)\u00a0vaccine candidate. RSV is a common,\u00a0contagious\u00a0respiratory virus\u00a0that attacks the lungs and breathing passageways.\u00a0There is currently no approved vaccine for RSV, but an ongoing uptick in cases has led to an increased fervor of development.<\/p>\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>(Contagion Live) Codagenix Inc. announced the US Food and Drug Administration (FDA) recently granted Fast Track designation to CodaVax-RSV, their\u00a0respiratory syncytial virus (RSV)\u00a0vaccine candidate. RSV is a common,\u00a0contagious\u00a0respiratory virus\u00a0that attacks the lungs and breathing passageways.\u00a0There is currently no approved vaccine for RSV, but an ongoing uptick in cases has led to an increased fervor of [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,43,47],"tags":[],"class_list":["post-1311","post","type-post","status-publish","format-standard","hentry","category-emerging-infectious-diseases","category-rsv","category-rsv-therapies"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/1311","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/comments?post=1311"}],"version-history":[{"count":1,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/1311\/revisions"}],"predecessor-version":[{"id":1312,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/1311\/revisions\/1312"}],"wp:attachment":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/media?parent=1311"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/categories?post=1311"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/tags?post=1311"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}